JP2003523171A5 - - Google Patents

Info

Publication number

JP2003523171A5

JP2003523171A5 JP2000593138A JP2000593138A JP2003523171A5 JP 2003523171 A5 JP2003523171 A5 JP 2003523171A5 JP 2000593138 A JP2000593138 A JP 2000593138A JP 2000593138 A JP2000593138 A JP 2000593138A JP 2003523171 A5 JP2003523171 A5 JP 2003523171A5

Authority

JP

Japan

Prior art keywords

seq

polynucleotide

group

detecting

fragments

Prior art date

2000-01-19

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108091033319 polynucleotide Proteins 0.000 description 38
• 102000040430 polynucleotide Human genes 0.000 description 38
• 239000002157 polynucleotide Substances 0.000 description 38
• 238000000034 method Methods 0.000 description 29
• 239000012634 fragment Substances 0.000 description 18
• 229920001184 polypeptide Polymers 0.000 description 15
• 102000004196 processed proteins & peptides Human genes 0.000 description 15
• 108090000765 processed proteins & peptides Proteins 0.000 description 15
• 239000000427 antigen Substances 0.000 description 13
• 102000036639 antigens Human genes 0.000 description 13
• 108091007433 antigens Proteins 0.000 description 13
• 239000007790 solid phase Substances 0.000 description 11
• 125000003275 alpha amino acid group Chemical group 0.000 description 10
• 230000009870 specific binding Effects 0.000 description 9
• 108091034117 Oligonucleotide Proteins 0.000 description 8
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 7
• 239000007795 chemical reaction product Substances 0.000 description 6
• 150000007523 nucleic acids Chemical class 0.000 description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 description 5
• 208000030270 breast disease Diseases 0.000 description 5
• 108091093088 Amplicon Proteins 0.000 description 3
• 230000002745 absorbent Effects 0.000 description 3
• 239000002250 absorbent Substances 0.000 description 3
• 239000004744 fabric Substances 0.000 description 3
• 238000003259 recombinant expression Methods 0.000 description 3
• 229920000742 Cotton Polymers 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000027455 binding Effects 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1